Global Wealth Strategies & Associates’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$498K Buy
430
+99
+30% +$117K 0.09% 58
2026
Q2
$397K Sell
331
-49
-13% -$50.1K 0.08% 66
2026
Q1
$350K Sell
380
-18
-5% -$18.2K 0.09% 61
2025
Q4
$428K Buy
398
+56
+16% +$53.5K 0.11% 47
2025
Q3
$261K Sell
342
-30
-8% -$22.3K 0.07% 62
2025
Q2
$290K Sell
372
-31
-8% -$24.1K 0.08% 47
2025
Q1
$333K Sell
403
-178
-31% -$148K 0.1% 41
2024
Q4
$449K Sell
581
-5
-0.9% -$4.14K 0.14% 33
2024
Q3
$519K Sell
586
-41
-7% -$36.9K 0.17% 26
2024
Q2
$568K Buy
627
+14
+2% +$11.2K 0.2% 25
2024
Q1
$477K Sell
613
-15
-2% -$10.7K 0.18% 28
2023
Q4
$366K Sell
628
-15
-2% -$8.76K 0.15% 29
2023
Q3
$345K Sell
643
-20
-3% -$10.3K 0.16% 34
2023
Q2
$311K Hold
663
– – 0.15% 34
2023
Q1
$228K Hold
663
– – 0.12% 37
2022
Q4
$243K Buy
+663
New +$235K 0.14% 38

Other funds holding LLY

Global Wealth Strategies & Associates's LLY Position: Q3 2026 in Review

Global Wealth Strategies & Associates increased its Eli Lilly (LLY) stake by 30% in Q3 2026, buying an estimated $117K and bringing the position to 430 shares worth $498K. The position accounts for 0.09% of the portfolio, ranked #58.

Global Wealth Strategies & Associates first reported a position in LLY in Q4 2022 and has held it in 16 quarters since. The position peaked at $568K in Q2 2024. 428 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Global Wealth Strategies & Associates held 430 shares of Eli Lilly worth $498K as of Q3 2026.
  • Global Wealth Strategies & Associates bought 99 Eli Lilly shares in Q3 2026, an estimated $117K.
  • Eli Lilly made up 0.09% of Global Wealth Strategies & Associates's portfolio in Q3 2026, its #58 holding.
  • Global Wealth Strategies & Associates first reported a position in Eli Lilly in Q4 2022 and has held it in 16 quarters since.
  • Global Wealth Strategies & Associates's Eli Lilly position peaked at $568K in Q2 2024.
  • 428 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Global Wealth Strategies & Associates's 13F filing for Q3 2026, filed 2 Oct 2026.